Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod 5 System


Benzinga | Jun 24, 2021 06:06AM EDT

Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod 5 System

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod(r) brand of products, today announced its schedule of events for the American Diabetes Association (ADA) Virtual 81st Scientific Sessions June 25 -- 29, 2021.

Following the release of its initial pivotal trial results in March, Insulet will present new clinical outcomes data for preschool children with type 1 diabetes using the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the first tubeless automated insulin delivery system with the option for full control by a user's compatible smartphone to simplify life for people living with diabetes. The Company will also report additional results from the Omnipod 5 pivotal study in people aged 6 through 70 years living with type 1 diabetes, including clinical outcomes after transitioning from multiple daily injections, the Company's three-month pivotal extension study results that includes six months of system use, and quality of life and satisfaction data.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC